Ignite Creation Date:
2024-07-17 @ 10:43 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06488690
Status:
COMPLETED
Last Update Posted:
2024-07-05
First Post:
2024-06-27
Brief Title:
Early Warning Scores in Pregnant Woman
Sponsor:
Suleyman Demirel University
Organization:
Suleyman Demirel University
Study Overview
Official Title:
Effectiveness of Early Warning Scores Preoperative Period in Pregnant Women
Status:
COMPLETED
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Our study aims to evaluate the use of early warning scores as a screening tool to predict obstetric mortality and morbidity in pregnant women who will undergo cesarean section
Detailed Description:
Our study aims to evaluate the use of early warning scores as a screening tool to predict obstetric mortality and morbidity in pregnant women who will undergo cesarean section
This prospective study included 304 patients undergoing cesarean section at Suleyman Demirel University between April 2022 and April 2023 Physiological parameters were assessed in all 304 pregnant women before the operation Maternal early warning scores including modified early obstetric warning score MEOWS maternal early warning score MEWC and maternal early warning triggers MEWT were calculated for each patient Patients triggering the system were classified as Group 1 risky patients while those not triggering the system were classified as Group 2 risk-free patients
This prospective study included 304 patients undergoing cesarean section at Suleyman Demirel University between April 2022 and April 2023 Physiological parameters were assessed in all 304 pregnant women before the operation Maternal early warning scores including modified early obstetric warning score MEOWS maternal early warning score MEWC and maternal early warning triggers MEWT were calculated for each patient Patients triggering the system were classified as Group 1 risky patients while those not triggering the system were classified as Group 2 risk-free patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None